NCT05964946View on ClinicalTrials.gov

Real-life Study of the Characteristics of Patients Treated With Ilaris® (Canakinumab) for Gouty Arthritis in France

CompletedOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

June 24, 2020

Primary Completion Date

July 29, 2022

Study Completion Date

July 29, 2022

Conditions
Gouty Arthritis
Trial Locations (1)

92506

Novartis, Paris

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY